Blood clotting risks in inflammatory bowel disease
Part of Digestive system clinical trials.
This study looks at whether people with inflammatory bowel disease (IBD) have a higher risk of blood clots when the disease is active versus in remission. It may help understand how to better prevent clotting problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- You have been diagnosed with inflammatory bowel disease (Crohn's disease or ulcerative colitis).
- You are not currently pregnant.
- You have not had surgery recently.
- You have no history of cancer, blood disorders, or blood transfusions in the last month.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at certain blood cell markers (platelets) in people with inflammatory bowel disease (ulcerative colitis or Crohn's) to see if these markers relate to disease activity. It may help doctors better understand and monitor your condition.
This study looks at whether certain blood markers can help measure disease activity in people with Crohn's disease or ulcerative colitis. It involves reviewing medical records and may include a colonoscopy if you have one done as part of your routine care.
This study looks at changes in fats (lipids) in the blood and the lining of the gut in people with inflammatory bowel disease (IBD). It may help researchers understand IBD better and find new ways to treat it.
This study collects and stores information and samples from people with inflammatory bowel disease (IBD) to help researchers learn more and improve care. Your participation mainly helps build a “biobank,” which can support future studies.
This study looks at what factors help predict how inflammatory bowel disease (IBD) may progress over time. You may be able to join if you are an adult with IBD and fit one of the study groups based on whether you have used TNF-blocking medicines before.
This study looks at how a leaky gut might increase the risk of blood clots and blood vessel damage in people with inflammatory bowel disease (IBD). It may help researchers understand new ways to prevent complications.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.